Assessing the Implications of Financial Requirements on Commercial Copay Assistance Program
Case Study:
Optimizing a Commercial Copay Assistance Program
This case study outlines how a pharmaceutical company evaluated the impact of Federal Poverty Level (FPL) criteria on their commercial copay assistance program for a new diabetes medication.
Key highlights include:
- Challenge: Balance competitiveness in the diabetes space with concerns about copay program costs and patient enrollment criteria.
- Approach: Magnolia conducted competitive benchmarking, analyzed payer mix and patient cost-sharing, and tested FPL scenarios to assess the impact of raising the criteria.
- Outcome: Adjusting FPL criteria to 400% resulted in a $39.2M reduction in copay support costs over three years, a 54% decrease in eligible patients, and reduced program administration costs by $3.8M.
Download the case study to discover how strategic adjustments to assistance programs can optimize costs while maintaining competitiveness.
